The Defense Health Agency (DHA) has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Verogen, Inc. for the provision of testing reagents and consumables to support the agency's genomic sequencing initiatives. The contract, valued at $46,967.19, is for the delivery of products such as MiSeq reagent kits, NextSeq systems, and ForenSeq kits. This BPA, which has no set-aside designation, was originally awarded to Verogen in November 2023 and runs through October 2028. Verogen, a...
This contract was awarded by the Defense Health Agency to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The $153,135.25 Blanket Purchase Agreement (BPA) Call is for the delivery of MiSeq Reagent Kits, a type of next-generation sequencing consumable. The contract is a firm fixed-price vehicle without a small business set-aside designation. Verogen has previously supported the Defense Health Agency, Federal Bureau of Investigation, U.S. Army...
This is a firm fixed price BPA call order awarded by the Defense Health Agency to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The contract is for the delivery of 200 units of the MiSeq Reagent Kit, a product used in next-generation DNA sequencing, with a potential value of $328,339.49 and a completion date of August 2, 2023. Verogen has previously provided sequencing systems, reagents, and technical services to support the Defense Health...
The Defense Health Agency has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing. This $81,521.36 contract provides the agency with ForenSeq mitochondrial DNA (mtDNA) whole genome sequencing kits and consumables to support its genomic sequencing initiatives. Verogen holds a $7,433,000 single-award BPA with the Defense Health Agency, awarded in November 2023, to supply a range...
This federal contract award is for the supply of REAGENT KITS to the Defense Health Agency (DHA), a component of the U.S. Department of Defense. The prime contractor is Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The contract is a Blanket Purchase Agreement (BPA) Call with a ceiling value of $88,695.32 and a performance period ending on March 27, 2025. The contract is a Firm Fixed Price arrangement and does not utilize any small business...
This is a firm fixed price BPA call contract awarded by the Defense Health Agency to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The contract is for the delivery of MiSeq sequencing systems, ForenSeq reagent kits, next-generation sequencing reagents and consumables, and technical support services, with a potential value of $117,480.37. Verogen has previously provided similar products and services to federal agencies such as the FBI, Army...
This firm fixed-price contract award to Verogen, Inc. by the Defense Health Agency is a BPA call order valued at $225,050.22. It does not have a set-aside designation. The contract is for the procurement of MiSeq RGT KIT V3 (150) sequencing reagents and consumables to support the agency's genomic sequencing programs. Verogen is a biotechnology company that specializes in forensic genomics and DNA sequencing, and has previously provided similar products and services to federal agencies such as...
This contract award to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing, was made by the Defense Health Agency. The $45,483.03 firm-fixed-price contract provides for the delivery of ForenSeq Kintelligence KT reagents, which are used in next-generation DNA sequencing systems. This is a Blanket Purchase Agreement (BPA) call, part of a larger $7,433,000 single-award BPA that Verogen holds with the Defense Health Agency. The BPA allows the agency...
This is a firm fixed-price contract awarded by the Defense Health Agency to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing. The contract, valued at $413,414.01, is for the provision of MiSeQ RGT V3 sequencing systems, reagents, consumables, and technical support services. The contract is a Blanket Purchase Agreement (BPA) call, which allows the agency to procure standardized laboratory supplies to support its genomic sequencing programs....
This is a firm fixed price contract awarded by the Defense Health Agency to Verogen, Inc., a biotechnology research company that specializes in forensic genomics and DNA sequencing. The contract has a potential value of $235,984.48 and does not have a set-aside designation. Through this contract, Verogen will provide the Defense Health Agency with various products and services related to next-generation DNA sequencing, including MiSeq FGx sequencing systems, ForenSeq reagent kits, sequencing...